IFN-β-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: Relevance to IFN-β-1b therapeutic effects in multiple sclerosis

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 548-557

  Wang, Xin ^a,b   Chen, Man ^a,b   Wandinger, Klaus Peter ^c   Williams, Gary ^d   Dhib Jalbut, Suhayl ^a,b,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d BAYER AG   (Germany)

^e UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; INTERLEUKIN 10; INTERLEUKIN 12;

ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034234528     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.548     Document Type: Article

References (47)

1. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. London, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
2. Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y.-C.E. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite, et al. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808.
3. Trinchieri, G. 1998. Interleukin-12: a cytokine al the interface of inflammation and immunity. Adv. Immunol. 70:83.
4. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr. Opin. Immunol. 9:17
5. + T cells occurs through macrophage production of IL-12. Science 260: 547.
6. Manetti, R., F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M. P. Piccinni, S. Xampognaro, E. Maggi, S. Romagnani, and G. Trinchieri. 1994. Interleukin-12 induces stable priming for interferon-γ (TFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179: 1273.
7. Karp, C. L. 1999. Interleukin-12: amiss in MS. Ann. Neurol. 45:689.
8. Matusevicius, D., P. Kivisakk, V. Navikas, M. Soderstrom, S. Fredrikson, and H. Link. 1998. interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis. Scand. J. Immunol. 47:582.
9. Comabella, M., K. Balashov, S. Issazadeh, D. Smith, H. L. Weiner, and S. J. Khoury. 1998. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. Clin. Invest. 102, 671.
10. + T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94:599.
11. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:2499.
12. Nicoletti, F., F. Patti, C. Cocuzza, P. Zaccone, A. Nicoletti, R. Di Marco, and A. Reggio. 1996. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 70:87.
13. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
14. Fassbender, K., A. Ragoschke, S. Rossol, A. Schwartz, O. Mielke, A. Paulig, and M. Hennerici. 1998. Increased release of interleukin-12 p40 in MS: association with intracerebral inflammation. Neurology 51:753.
15. Ferrante, P., M. L. Fusi, M. Saresella, D. Caputo, M. Biasin, D. Trabattoni, A. Salvaggio, E. Clerici, J. E. de Vries, G. Aversa, et al. 1998. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. J. Immunol. 160:1514.
16. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
17. Leonard, J. P., K. E. Waldburger, R. G. Schaub, T. Smith, A. K. Hewson, M. L. Cuzner, and S. J. Goldman. 1997. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Crit. Rev. Immunol. 17:545.
18. Segal, B. M., B. K. Dwyer, and E. M. Shevach. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med 187:537.
19. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495.
20. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with γ Interferon. Lancet 1:893.
21. The IFNβ-1b Multiple Sclerosis Study Group. 1993. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. Neurology 43:655.
22. Jacobs, L. D., D. L. Cookfair, R. A. Rudick, R. M. Herndon, J. R. Richert, A. M. Salazar, J. S. Fischer, D. E. Goodkin, C. V. Granger, J. H. Simon, et al. 1996. Intramuscular interferon β-1a for disease progression in relapsing multiple sclerosis. Ann Neurol. 39:285.
23. Dhib-Jalbut, S. 1997. Mechanisms of interferon β action in multiple selerosis. Mult. Scler. 3:397.
24. Vergelli, M., B. Hemmer, U. Utz, A. Vogt, M. Kalbus, L. Tranquill, P. Conlon, N. Ling, L. Steinman, H. F. McFarland, et al. 1996. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26:2624.
25. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6:986.
26. Weiner, J., C. K. Jung, I. Shackel, and P. M. Williams. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270:41.
27. Fulton, S. A., J. V. Cross, Z. T. Toossi, and W. H. Boom. 1998. Regulation of interleukin-12 by interleukin-10, transforming growth factor-β, tumor necrosis factor-α, and interferon-γ in human monocytes infected with mycobacterium tuberculosis H37Ra. J. Infect. Dis. 178:1105.
28. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E., Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine den-dritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
29. Rudick, R. A., R. M. Ransohoff, R. Peppler, S. V. Medendorp, P. Lehmann, and J. Alam. 1996. Interferon β induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 40:618.
30. Williams, G. J., and P. L. Witt. 1998. Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX. J. Interferon Cytokine Res. 18:967.
31. Khan, O. A., Q. Xia, C. T. Bever, Jr., K. P. Johnson, H. S. Panitch, and S. S. Dhib-Jalbut. 1996. Interferon β-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 46:1639.
32. Dhib-Jalbut, S., H. Jiang, Q. Xia, L. Blatt, K. P. Johnson, and D. Hilt. 1996. Comparative effects of interferon-consensus 1, interferon-α2a, and interferon-β1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis. J. Interferon Cytokine 16:195.
33. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634.
34. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and A. Biron. 1999. Two roads diverged: inlerferon α/β- and interleukin 12-medialed pathways in promoting T cell Interferon γ responses during viral infection. J. Exp. Med. 189:1315.
35. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 83:147.
36. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:5258.
37. Ma, X., M. Neurath, G. Gri, and G. Trinchieri. 1997. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human inlerleukin-12 p40 gene promoter. J. Biol. Chem. 272:10389.
38. Scharton-Kersten, T., C. Contursi, A. Masumi, A. Sher, and K. Ozato. 1997. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1523.
39. Giese, N. A., L. Gabriele, T. M. Dopherty, D. M. Klinman, L. Tadesse-Heath, C. Contursi, S. L. Epstein, and H. C. Morse, III. 1997. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186:1535.
40. Darnell, J. E ., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
41. Martin, R., and H. F. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis Crit. Rev. Clin. Lab. Sci. 32: 121.
42. Pardoux, C., X. Ma, S. Gobert, S. Pellegrini, P. Mayeux, F. Gay, G. Trinchieri, and S. Chouaib. 1999 Downregulation of interleukin-12 (1L-12) responsiveness in human T cells by transforming growth factor-β: relationship with IL-12 signaling. Blood 93:1448.
43. Aste-Amezaga, M., X. Ma, A. Sanori, and G. Trinchieri. 1998. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160: 5936.
44. Becher, B., V. Dodelet, V. Fedorowicz, and J. P. Antel. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1539.
45. Karp, C. L., M. Wysocka, X. Ma, M. Marovich, R. E. Factor, T. Nutman, M. Armant, L. Wahl, P. Cuomo, and G. Trinchieri. 1998. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur. J. Immunol. 28:3128.
46. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228.
47. van Boxel-Dezaire, A. H., S. C. Hoff, B. W. van Oosten, C. L. Verweij, A. M. Drager, H. J. Ader, J. C. van Houwelingen, F. Barkhof, C. H. Polman, and L. Nagelkerken. 1999. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45:695.